PRPO
Precipio, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$26.46
+0.08%Next report
Analyst consensus
- Next report date
- Nov 16, 2026
- EPS estimate
- -$2.00
- Revenue estimate
- $1.7M
Latest reported
- Last report date
- Aug 17, 2026
- EPS actual
- -$0.12
- EPS estimate
- -$2.00
- Revenue actual
- $7.0M
- Revenue estimate
- $1.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -413.5%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 17, 2026 | -$2.00 | -$0.12 | Beat 94.00% | $7.0M |
| Mar 30, 2026 | — | $0.33 | — | $8.0M |
| Nov 14, 2025 | — | -$0.05 | — | $6.2M |
| Aug 13, 2025 | — | $0.05 | — | $5.7M |
| May 14, 2025 | — | -$0.59 | — | $4.3M |
| Mar 27, 2025 | $0.74 | -$0.23 | Miss -131.08% | $5.5M |
| Aug 13, 2024 | -$0.05 | -$0.83 | Miss -1560.00% | $4.4M |
| May 14, 2024 | -$0.93 | -$1.46 | Miss -56.99% | $3.4M |
| Mar 29, 2024 | -$0.93 | -$0.41 | Beat 55.91% | $4.3M |
| Nov 13, 2023 | -$1.21 | -$1.04 | Beat 14.05% | $3.7M |
| Aug 11, 2023 | -$0.10 | -$1.80 | Miss -1700.00% | $3.5M |
| May 12, 2023 | -$0.13 | -$2.60 | Miss -1900.00% | $2.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 16, 2026